Try our beta test site
106 studies found for:    Open Studies | "Pulmonary Fibrosis"
Show Display Options
Rank Status Study
21 Recruiting Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Pulmonary Fibrosis
Intervention:
22 Recruiting Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: ART-123;   Drug: Placebo
23 Recruiting Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
24 Recruiting Early Diagnosis of Pulmonary Fibrosis - Use of Biomarkers in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
25 Recruiting Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Behavioral: Physical exercise training;   Behavioral: Cognitive exercise training
26 Not yet recruiting A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Valganciclovir;   Drug: Placebo
27 Recruiting 68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary Fibrosis
Condition: Pulmonary Fibrosis, Unspecified
Interventions: Drug: 68Ga-NOTA-PRGD2;   Device: PET/CT
28 Recruiting Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Cyclophosphamide;   Drug: Placebo;   Drug: Corticosteroid (prednisolone)
29 Recruiting A Study of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: lebrikizumab;   Drug: pirfenidone;   Drug: placebo
30 Recruiting PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
31 Not yet recruiting Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
32 Recruiting Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
33 Recruiting Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Nintedanib;   Drug: Pirfenidone
34 Recruiting Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: nintedanib;   Drug: placebo
35 Recruiting Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
36 Recruiting Efficacy and Safety of Nintedanib When Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Nintedanib;   Drug: Placebo;   Drug: Sildenafil
37 Recruiting Nebulized Fentanyl in Patients With Mild to Moderate Idiopathic Pulmonary Fibrosis and Chronic Dyspnea
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Fentanyl Citrate;   Drug: Placebo
38 Recruiting STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Interventions: Drug: BG00011;   Drug: Placebo
39 Recruiting Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention: Drug: Dasatinib + Quercetin
40 Recruiting Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.